Proteome Sciences plc provided earnings guidance for the full year ending December 31, 2019. For the period, the company expects Group unaudited revenues to be approximately £4.7 million (2018: £3.0 million) representing a year on year growth of 57%. The updated TMT® sales and royalties accounted for approximately £3.7 million (2018: £2.2 million) of this total, reflecting a 68% year on year growth including the milestone payment of approximately £0.75 million and 34% growth of the underlying sales. The Company anticipates a profit after tax of approximately £0.2 million (2018: loss of £1.3 million). All other figures remain as reported in the Trading Update dated 21 January 2020.